[1] 赵心明. 钆塞酸二钠增强MRI的临床应用及前景[J]. 中华放射学杂志, 2019, 53(12): 1025.
[2] DAVENPORT MS, VIGLIANTI BL, AL-HAWARY MM, et al. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine. effect on arterial phase image quality[J]. Radiology, 2013, 266(2): 452. doi: 10.1148/radiol.12120826
[3] 周围, 柏根基, 单文莉, 等. 普美显MRI增强检查对肝细胞肝癌定性诊断的价值[J]. 实用放射学杂志, 2019, 35(7): 1073. doi: 10.3969/j.issn.1002-1671.2019.07.011
[4] 徐晓莉, 冯峰, 张涛, 等. 钆塞酸二钠增强磁共振T1弛豫时间及肝细胞分数对肝纤维化分期的评估价值[J]. 山东医药, 2021, 61(26): 10.
[5] 黄贤平, 周观林, 钟万. 钆塞酸二钠增强磁共振成像在慢性肝炎背景下小肝癌诊断中的应用价值[J]. 医疗装备, 2019, 31(11): 9.
[6] 石川, 孙志超. 肝特异性造影剂增强对信号噪声比率、T2弛豫时间和表观扩散系数值的影响[J]. 蚌埠医学院学报, 2017, 42(8): 1106.
[7] RINGE K, LUETKENS J, FIMMERS R, et al. Characterization of severe arterial phase respiratory motion artifact on gadoxetate Disodium-Enhanced MRI-assessment of interrater agreement and reliability[J]. Rofo, 2018, 190(4): 341. doi: 10.1055/s-0044-100727
[8] KRISTINA IR, FALCK CV, HANS-JVRGENR, et al. Evaluation of transient respiratory motion artifactat gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols[J]. PLoS One, 2018, 13(7): e0200887. doi: 10.1371/journal.pone.0200887
[9] 中华医学会放射学分会腹部学组. 肝胆特异性MRI对比剂钆塞酸二钠临床应用专家共识[J]. 中华放射学杂志, 2016, 50(9): 641.
[10] 陈莉玲, 梁雪梅, 贺小红, 等. 普美显2种注射方法对MRI增强扫描的图像质量影响及护理分析[J]. 现代医药卫生, 2019, 35(24): 3838.
[11] 何燕, 杨君, 胡永超. 优化钆塞酸二钠注射液推注速度对MRI检查的作用效果分析[J]. 医药高职教育与现代护理, 2021, 4(4): 328.
[12] WANG JH, CHEN TY, OU HY, et al. Clinical Impact of gadoxetic acid-enhanced magnetic resonance imagingon hepatoma management: a prospective study[J]. Dig Dis Sci, 2016, 61(4): 1197.
[13] KIM HD, LIM YS, HAN S, et al. Evaluation of Early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival[J]. Gastroenterology, 2015, 148(7): 1371.
[14] MATSUDA M, ICHIKAWA T, AMEMIYA H, et al. Preoperative gadoxetic acid enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection[J]. HPB Surg, 2014, 2014: 641685.
[15] KIM SY, AN J, LIM YS, et al. MRI with liver specific contrastfor surveillance of patients with cirrhosisat high risk of hepatocellular carcinoma[J]. JAMA Oncol, 2017, 3(4): 456.
[16] HESHMATZADEH BEHZADI A, FAROOQ Z, NEWHOUSE JH, et al. MRI and CT contrast media extravasation: a systematic review[J]. Medicine (Baltimore), 2018, 97(9): e0055.
[17] American College of Radiology. ACR manual on contrast media, version 10.3[M]. ACR Committee on Drugs and Contrast Media, 2018. http://www.acr.org/Contrast-Manual.
[18] 李静, 孙燕霞, 唐磊, 等. 呼吸训练联合音乐疗法对门诊患者肝脏MRI增强扫描效果的影响[J]. 上海护理, 2019, 19(6): 13.
[19] LUETKENS JA, PATRICK AK, DOERNER J, et al. Respiratory motion artefacts in dynamic liver MRI: acomparison using gadoxetate disodium and gadobutrol[J]. Eur Radiol, 2015, 25(11): 3207.
[20] JI SS, CHOI EJ, EUN HP, et al. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method[J]. Eur Radiol, 2018, 28(3): 1132.